Annovis Bio, Inc. (ANVS)

USD 1.61

(2.55%)

Eps Summary of Annovis Bio, Inc.

  • Annovis Bio, Inc.'s latest annual eps in 2023 was -6.23 USD , down -102.27% from previous year.
  • Annovis Bio, Inc.'s latest quarterly eps in 2024 Q1 was -0.10 USD , up 95.71% from previous quarter.
  • Annovis Bio, Inc. reported an annual eps of -3.08 USD in 2022, down -62.96% from previous year.
  • Annovis Bio, Inc. reported an annual eps of -1.89 USD in 2021, down -182.09% from previous year.
  • Annovis Bio, Inc. reported a quarterly eps of -0.10 USD for 2024 Q1, up 95.71% from previous quarter.
  • Annovis Bio, Inc. reported a quarterly eps of -1.07 USD for 2023 Q2, up 70.19% from previous quarter.

Annual Eps Chart of Annovis Bio, Inc. (2023 - 2017)

Historical Annual Eps of Annovis Bio, Inc. (2023 - 2017)

Year Eps Eps Growth
2023 -6.23 USD -102.27%
2022 -3.08 USD -62.96%
2021 -1.89 USD -182.09%
2020 -0.67 USD -1443.78%
2019 -0.07 USD 72.88%
2018 -0.16 USD 0.0%
2017 -0.16 USD 0.0%

Peer Eps Comparison of Annovis Bio, Inc.

Name Eps Eps Difference
ADC Therapeutics SA -2.94 USD -111.905%
Alto Neuroscience, Inc. -1.35 USD -361.481%
Biohaven Pharmaceutical Holding Company Ltd. -5.73 USD -8.726%
Ginkgo Bioworks Holdings, Inc. -18.37 USD 66.086%
Nuvation Bio Inc. -0.35 USD -1680.0%
Nuvation Bio Inc. -0.35 USD -1680.0%
Arcus Biosciences, Inc. -4.15 USD -50.12%
Zymeworks Inc. -1.72 USD -262.209%